Topic

Managing inflammatory CNVM in uveitis

Solving the diagnostic and treatment challenges of choroidal neovascular membrane in uveitis.

An update on diagnosis and treatment, including the role of multimodal imaging and combination therapy.

A review of neoplastic and nonneoplastic masqueraders that can confound and complicate diagnosis.

Uveitis-glaucoma-hyphema syndrome, or Ellingson syndrome, requires surgery targeting the intraocular lens to resolve the cause of chafing.

A review of local and systemic treatments for UME and insights on when to use them.

Immune checkpoint inhibitors are becoming more widely available, but they’ve been linked to uveitis in some patients.

A review of the available evidence and anecdotal reports supporting their use.

Treatments show potential for various posterior-segment diseases based on their success treating noninfectious uveitis.

An update on biologic alternatives for ocular inflammatory disease when the approved agent just won’t cut it.

The pandemic has potentially changed the risk-benefit balance between local therapy and systemic immunosuppression.